Immunomorphological features of female patient’s skin with androgenetic alopecia in the treatment of platelet-rich plasma in combination with topical minoxidil 2 % lotion
The aim. The research was provided to obtain immunohistochemical changes in scalp biopsies of female patients with androgenetic alopecia (AGA) I-II stages according to the Ludwig scale and to detect possible changes after usage of platelet-rich plasma (PRP) injections in combination with topical minoxidil 2 % lotion.
Materials and methods. Skin biopsies of 30 patients with AGA were examined by immunohistochemistry before and after treatment, which lasted for 3 months and included 3 PRP sessions (once per month) and topical application of minoxidil 2 % lotion twice daily.
Results. It was found that AGA is accompanied by inflammatory perifollicular infiltration by T-lymphocytes CD3 +, CD4 + and CD8 +, macrophages (CD68 +); imbalance of growth polypeptides VEGF, TGF-β1, EGFR; accumulation of oxidative stress enzymes eNOS and iNOS; accumulation of pathological fraction of Collagen IV. The use of platelet-rich plasma in combination with topical 2 % minoxidil as AGA therapy leads to the normalization of immunohistochemical parameters of the skin, which indicates the possibility of its use for long-term therapeutic effect.
Conclusions. This study supplemented the understanding of the pathogenesis of AGA and serves as the basis for improving treatment regimens for this pathology. But more research is required to further study the pathomorphology of androgenetic alopecia and to standardize the technique of using platelet-rich plasma in patients with this disease.
Kaliyadan, F., Nambiar, A., Vijayaraghavan, S. (2013). Androgenetic alopecia: An update. Indian Journal of Dermatology, Venereology, and Leprology, 79 (5), 613–625. doi: http://doi.org/10.4103/0378-6323.116730
Ovcharenko, Y., Salyenkova, O. (2021). Modern concept of the etiology and pathogenesis of androgenetic alopecia. The Journal of V. N. Karazin Kharkiv National University, Series “Medicine”, 42, 92–100. doi: http://doi.org/10.26565/2313-6693-2021-42-11
Rojas-Martínez, A., Martinez-Jacobo, L., Villarreal-Villarreal, C., Ortiz-López, R., Ocampo-Candiani, J. (2018). Genetic and molecular aspects of androgenetic alopecia. Indian Journal of Dermatology, Venereology and Leprology, 84 (3), 263–268. doi: http://doi.org/10.4103/ijdvl.ijdvl_262_17
Ovcharenko, Y. S., Salyenkova, O. A. (2020). Analysis of expediency to use platelet-enriched plasma for treatment of androgenetic alopecia. International Medical Journal, 1, 64–67. doi: http://doi.org/10.37436/2308-5274-2020-1-14
Anitua, E., Pino, A., Martinez, N., Orive, G., Berridi, D. (2017). The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study. Dermatologic Surgery, 43 (5), 658–670. doi: http://doi.org/10.1097/dss.0000000000001049
Alves, R., Grimalt, R. (2016). Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. Dermatologic Surgery, 42 (4), 491–497. doi: http://doi.org/10.1097/dss.0000000000000665
Avtandilov, G. G. (2002). Osnovy kolichestvennoi patologicheskoi anatomii. Moscow: Meditsina, 240.
Upton, J. H., Hannen, R. F., Bahta, A. W., Farjo, N., Farjo, B., Philpott, M. P. (2015). Oxidative Stress–Associated Senescence in Dermal Papilla Cells of Men with Androgenetic Alopecia. Journal of Investigative Dermatology, 135 (5), 1244–1252. doi: http://doi.org/10.1038/jid.2015.28
Varothai, S., Bergfeld, W. F. (2014). Androgenetic Alopecia: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology, 15 (3), 217–230. doi: http://doi.org/10.1007/s40257-014-0077-5
👁 174 ⬇ 165
Copyright (c) 2021 Olena Salyenkova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.